Confining copper nanoclusters on exfoliation-free 2D boehmite nanosheets: Fabrication of ultra-sensitive sensing platform for α-glucosidase activity monitoring and natural anti-diabetes drug screening

Sihan Chen,Zheng Li,Wenjun Li,Zhenzhen Huang,Qiong Jia

DOI: https://doi.org/10.1016/j.bios.2021.113198

IF: 12.545

2021-06-01

Biosensors and Bioelectronics

Abstract:α-Glucosidase (α-Glu) and its inhibitors play critical roles in diabetes therapy. Herein, a simple and ultra-sensitive fluorescence sensing approach was fabricated for α-Glu activity monitoring and natural inhibitor screening by electrostatically confining negatively charged glutathione-capped copper nanoclusters (GSH-CuNCs) on exfoliation-free and positively charged 2D boehmite (Boe) nanosheets. Boe significantly improved the fluorescence emission/stability of GSH-CuNCs and simultaneously led to an obvious blue-shift of the excitation peak of CuNCs from 365 nm to 330 nm. As a result, the fluorescence emission of Boe@GSH-CuNCs was efficiently quenched by 4-nitrophenyl-α-D-glucopyranoside (PNPG) with a maximum absorbance peak (λ_max) at 310 nm via inner filter effect, and sequentially recovered by α-Glu through the hydrolysis of PNPG to p-nitrophenol (λ_max = 410 nm). Accordingly, an ultra-sensitive fluorescence assay for the determination of α-Glu activity was proposed by using Boe@GSH-CuNCs as fluorescence probes. The detection limit of 0.43 U/L was achieved, which was lower than most of other α-Glu activity assays. Furthermore, this method was capable of screening α-Glu inhibitors originated from actinomycetes, peanut, sophora flower, celery, and orange as potential anti-diabetes drugs. Taken together, this work provided a promising strategy for clinical treatment of diabetes and discovery of anti-diabetes drugs.

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology